The area of fixation covaries with short‐term changes in visual acuity after anti‐vascular endothelial growth factor treatment in patients with diabetic macular oedema
NS Jakobsen, DA Larsen, T Bek - Acta Ophthalmologica, 2018 - Wiley Online Library
Purpose Diabetic maculopathy can be treated with intravitreal injection of vascular
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema
NS Jakobsen, DA Larsen, T Bek - Acta ophthalmologica, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Diabetic maculopathy can be treated with intravitreal injection of vascular
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
NS Jakobsen, DA Larsen, T Bek - Acta Ophthalmologica, 2018 - europepmc.org
PURPOSE: Diabetic maculopathy can be treated with intravitreal injection of vascular
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema
NS Jakobsen, DA Larsen, T Bek - Acta Ophthalmologica, 2018 - pure.au.dk
PURPOSE: Diabetic maculopathy can be treated with intravitreal injection of vascular
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
The area of fixation covaries with short‐term changes in visual acuity after anti‐vascular endothelial growth factor treatment in patients with diabetic macular oedema.
NS Jakobsen, DA Larsen, T Bek - Acta Ophthalmologica …, 2018 - search.ebscohost.com
Purpose: Diabetic maculopathy can be treated with intravitreal injection of vascular
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …
endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all …